AGP  TABLE OF CONTENTS

Emergence of a Debate: AGPs and Public Health
Human Health and Antibiotic Growth Promoters (AGPs): Reassessing the Risk
A. Bezoen, W. van Haren, J. C. Hanekamp

 
PART   I

1 THE ISSUE
1.1 Introduction
1.2 Objectives and Methods

2 ASSESSING THE RISK
2.1 Introduction
2.2 The Risk Chain
2.3 Questions and Answers

3 ANTIBIOTICS: USE AND RESISTANCE MECHANISMS
3.1 Summary
3.2 Antibiotics: Categories
3.3 Antibiotic Usage
3.4 Cellular Processes and Antibiotics
3.5 Bacterial Resistance and its Transfer: Basics
3.6 Biochemical Defence Mechanisms against antibiotics
3.7 Selective Pressure and Resistance

PART I I

4 BACTERIAL ANTIBIOTIC RESISTANCE AND HUMAN AND ANIMAL HEALTH
4.1 Summary
4.2 Introduction
4.3 'Spreading the Disease'
4.4 Infectious Bacteria
4.5 Resistance Selection through Antibiotics
4.6 Research Efforts and Data Compatibility

5 PREVALENCE OF BACTERIA RESISTANT TO ANTIBIOTICS
5.1 Introduction
5.2 Resistance Prevalence
5.3 Resistance to MLSB Antibiotics
5.4 Conjugational Transfer of Genetic Material
5.5 The Animal-Human Link?

REFERENCES